๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Immunoglobulin A Nephropathy

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases NCT07614477Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Tianjin Everest Medicines (China) Co.,Ltd. ยท Tests: EVER001 Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) NCT01802034n/a1 site๐Ÿ“ New York The Rogosin Institute Atacicept in Multiple Glomerular Diseases NCT06983028Phase 21 site๐Ÿ“ Brisbane Vera Therapeutics, Inc. ยท Tests: Atacicept Study of the Link Between Complement Activation and IgA Nephropathy Severity NCT05234463n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France ยท Tests: IgAN patients KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites๐Ÿ“ Chuncheon๐Ÿ“ Daegu๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Kidney Biopsy A Study of YKST02 in Participants With Primary IgA Nephropathy NCT07498673EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: YKST02 A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy NCT04557462Phase 3161 sites๐Ÿ“ Glendale๐Ÿ“ San Diego๐Ÿ“ San Dimas Novartis Pharmaceuticals ยท Tests: LNP023 A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site๐Ÿ“ Brisbane Climb Bio, Inc. ยท Tests: CLYM116, Placebo Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (โ‰ฅ18 Years) Primary IgA Nephropathy? NCT06676384Phase 412 sites๐Ÿ“ Nadiฤd๐Ÿ“ Mysuru๐Ÿ“ Udupi Christian Medical College, Vellore, India ยท Tests: Oral prednisolone and SoC, Gut-directed budesonide and SoC, Mycophenolate mofetil (MMF) and SoC, Hydroxychloroquine andโ€ฆ RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN) NCT06926244n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site๐Ÿ“ Jinan Zunsong Wang ยท Tests: Imaging Time A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563Phase 315 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Beijing Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease NCT07571746Phase 227 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Iowa City AstraZeneca ยท Tests: Surovatamig Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease NCT06989359Phase 238 sites๐Ÿ“ Doral๐Ÿ“ Miami๐Ÿ“ Pembroke Pines ADARx Pharmaceuticals, Inc. ยท Tests: ADX-038 Dose Level 2, ADX-038 Dose Level 1 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects NCT05942625Phase 11 site๐Ÿ“ Nanjing Hansoh BioMedical R&D Company ยท Tests: HS-10390 tablet, Placebo tablet Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant NCT05027906Phase 1, Phase 29 sites๐Ÿ“ Cincinnati๐Ÿ“ Camperdown๐Ÿ“ Adelaide Eledon Pharmaceuticals ยท Tests: AT-1501 A Study of JADE101 in Participants With Immunoglobulin A Nephropathy NCT07541287Phase 222 sites๐Ÿ“ Chula Vista๐Ÿ“ Arvada๐Ÿ“ Denver Jade Biosciences, Inc. ยท Tests: JADE101 A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event NCT07783802Phase 246 sites๐Ÿ“ Huntsville๐Ÿ“ Tucson๐Ÿ“ Tucson Eli Lilly and Company ยท Tests: Clazakizumab, Placebo A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. NCT07375758Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing Mabworks Biotech Co., Ltd. ยท Tests: MIL116, Matching Placebo Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Tamarac Walden Biosciences ยท Tests: WAL0921, Placebo IgA Nephropathy Biomarkers Evaluation Study (INTEREST) NCT02954419n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: No intervention A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) NCT07491900Phase 11 site๐Ÿ“ Brisbane Hinge Bio ยท Tests: HB2198 Effective Dosing of Burosumab in XLH NCT07183579n/a1 site๐Ÿ“ Nottingham University of Nottingham Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial NCT07056595NA1 site๐Ÿ“ Moscow Botkin Hospital ยท Tests: Finerenone Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis NCT06975787Phase 120 sites๐Ÿ“ San Francisco๐Ÿ“ Gainesville๐Ÿ“ Rochester Regeneron Pharmaceuticals ยท Tests: Vonsetamig, Odronextamab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy